Business
WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM
WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM ...
About this update from Atlas Energy Corp.
[{"type":"text","content":"\n \n \n \n WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n Company announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients\n \n \n \n \n Company anticipates\n \n \n revenue of over\n \n $1.0 million\n \n in Q2, and over\n \n $3.5 million\n \n for 2024 on existing programs\n \n \n \n \n Company expands its AI platform with the appointment of AI expert and industry veteran Dr.\n \n Richard Fox\n \n as Senior Advisor, AI Platform Technologies\n \n \n \n \n Company appoints Mr.\n \n Gregory Rocklin\n \n , as Senior Advisor, Business and Corporate Development to continue strategic partnership initiatives after securing the multi-product partnership with Laurus Labs\n \n \n \n \n Company announces its first patent being issued; anticipates filing another five patents in 2024 primarily related to its steroid production platform\n \n \n \n \n Company expands into the high growth biopesticide sector with addition of new partnered program\n \n \n \n \n \n SUNNYVALE, Calif.\n \n \n ,\n \n \n June 26, 2024\n \n \n /CNW/ - Willow Biosciences Inc. (\"\n \n Willow\n \n \" or the \"\n \n Company\n \n \") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable functional ingredients, announces a corporate update on its operations.\n \n \n \n \n \n \n \n \n \n \"The second quarter of 2024 has been the most active quarter to date for Willow's product portfolio,\" said Dr.\n \n Chris Savile\n \n , Willow's President & CEO. \"In addition to signing an agreement with global manufacturing giant, Laurus Labs, that added seven new programs in late May, Willow has added a new \"proof of concept\" agreement with an innovative biotech company in the high growth biopesticide sector,\" continued Dr. Savile.\n \n \n \n Laurus Labs Partnership\n \n \n \n...